Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-05-20 Purchase | 2022-05-23 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 39,000 | $0.2904 | $11,326 | 96,000 (Direct) | View |
| 2020-12-14 Purchase | 2020-12-16 9:00 pm | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 24,000 | $0.6896 | $16,550 | 57,000 (Direct) | View |
| 2020-06-29 Purchase | 2020-06-30 9:01 pm | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 33,000 | $1.62 | $53,460 | 33,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-15 Option Award | 2024-01-17 5:01 pm | N/A 2034-01-15 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 3,109,848 | $0 | 3,109,848 (Direct) | View |
| 2023-01-17 Option Award | 2023-01-17 9:04 pm | N/A 2033-01-17 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 1,915,056 | $0 | 1,915,056 (Direct) | View |
| 2022-01-12 Option Award | 2022-01-13 9:03 pm | N/A 2032-01-12 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 1,721,328 | $0 | 1,721,328 (Direct) | View |
| 2021-01-11 Option Award | 2021-01-11 9:03 pm | N/A 2031-01-11 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 1,329,528 | $0 | 1,329,528 (Direct) | View |
| 2020-04-01 Option Award | 2020-04-01 7:06 pm | N/A 2030-04-01 | Adaptimmune Therapeutics PLC | ADAP | Wood Gavin Chief Financial Officer | 3,065,000 | $0 | 3,065,000 (Direct) | View |